Warnings strengthened on tranquilizer inapsine (Droperidol).
SoRelle
R
R
D014150:Antipsychotic Agents / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004329:Droperidol / Q000009:adverse effects*; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced; D011358:Product Surveillance, Postmarketing; D016171:Torsades de Pointes / Q000139:chemically induced; D014481:United States; D014486:United States Food and Drug Administration
D014150:Antipsychotic Agents; D004329:Droperidol